KCC2 antagonism increases neuronal network excitability but disrupts ictogenesis in vitro.


Journal

Journal of neurophysiology
ISSN: 1522-1598
Titre abrégé: J Neurophysiol
Pays: United States
ID NLM: 0375404

Informations de publication

Date de publication:
01 09 2019
Historique:
pubmed: 25 7 2019
medline: 26 5 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

The potassium-chloride cotransporter 2 (KCC2) plays a role in epileptiform synchronization, but it remains unclear how it influences such a process. Here, we used tetrode recordings in the in vitro rat entorhinal cortex (EC) to analyze the effects of the KCC2 antagonist VU0463271 on 4-aminopyridine (4AP)-induced ictal and interictal activity. During 4AP application, ictal events were associated with significant increases in interneurons and principal cells activities. VU0463271 application transformed ictal discharges to shorter ictal-like events that were not accompanied by significant increases in interneuron or principal cell firing. Interictal events persisted during VU0463271 application at an accelerated frequency of occurrence with significant increases in interneuron and principal cell activity. Further analysis revealed that interneuron and principal cell firing rate during 4AP-induced interictal events were increased after VU0463271 application without changes in synchronicity. Overall, our results demonstrate that in the EC, KCC2 antagonism enhances both interneuron and principal cell excitability, while paradoxically decreasing the ability of neuronal networks to generate structured ictal events.

Identifiants

pubmed: 31339790
doi: 10.1152/jn.00266.2019
doi:

Substances chimiques

Potassium Channel Blockers 0
Symporters 0
4-Aminopyridine BH3B64OKL9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1163-1173

Subventions

Organisme : CIHR
ID : MOP-130328
Pays : Canada

Auteurs

Li-Yuan Chen (LY)

Montreal Neurological Hospital and Institute, Departments of Neurology and Neurosurgery, and of Physiology, McGill University, Montreal, Canada.

Maxime Lévesque (M)

Montreal Neurological Hospital and Institute, Departments of Neurology and Neurosurgery, and of Physiology, McGill University, Montreal, Canada.

Massimo Avoli (M)

Montreal Neurological Hospital and Institute, Departments of Neurology and Neurosurgery, and of Physiology, McGill University, Montreal, Canada.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH